[1]
M. Martha Lilac Ketisha Antoine and Y. Xu, “Sodium-glucose cotransporter-2 inhibitors: current knowledge on the use of canagliflozin, dapagliflozin and empagliflozin in the treatment of type 2 diabetes mellitus”, IJM, vol. 8, no. 1, pp. 8–12, Mar. 2020, doi: 10.14419/ijm.v8i1.30308.